A nurse is assisting with a training to newly licensed nurses about type 2 diabetes mellitus (DM). Which of the following statements by a newly licensed nurse indicates that the teaching was effective?

Choice A rationale

Monitoring thyroid stimulating hormone levels every 4 to 6 weeks is the standard of care during pregnancy because metabolic demands increase significantly as the fetus develops. Normal non-pregnant TSH levels typically range from 0.5 to 5.0 mIU/L, but during the first trimester, the goal is often lower to prevent developmental delays or miscarriage. Frequent testing ensures that the levothyroxine dosage remains therapeutic to meet the physiological requirements of both the mother and the growing fetus.

Choice B rationale

Doubling the dose of levothyroxine three times a week is an imprecise and potentially dangerous method of medication adjustment. While many pregnant women do require an increase in their thyroid hormone replacement, usually by 25 to 50 percent, this must be guided by specific lab results and provider orders. Indiscriminate dosing increases can lead to iatrogenic hyperthyroidism, which carries risks such as maternal tachycardia, hypertension, and potential fetal growth restriction due to excessive metabolic stimulation.

Choice C rationale

Cranberry juice does not have a known significant pharmacological interaction with the absorption or metabolism of levothyroxine. While certain substances like soy, walnuts, or high-fiber diets can interfere with how the body absorbs synthetic thyroid hormone, cranberry juice is generally considered safe. Patients should focus on consistent timing and avoiding actual inhibitors rather than restricting unrelated fluids. Maintaining adequate hydration is important during pregnancy, and cranberry juice is often used to support urinary tract health.

Choice D rationale

Prenatal vitamins often contain calcium and iron, both of which significantly impair the absorption of levothyroxine in the gastrointestinal tract. To ensure maximum bioavailability, levothyroxine should be taken on an empty stomach, and interfering substances like minerals should be separated by at least 4 hours, not just 2 hours. Taking them too close together can result in subtherapeutic hormone levels, leading to persistent hypothyroidism which can negatively impact fetal neurological development and maternal health.

Choice A rationale

Weight loss is a primary clinical indicator of hyperemesis gravidarum, typically defined as a loss of more than 5.

Choice B rationale

Abdominal cramping is not a typical manifestation of hyperemesis gravidarum and usually suggests other obstetric complications like spontaneous abortion, ectopic pregnancy, or gastrointestinal distress. Hyperemesis is characterized by upper gastrointestinal symptoms related to intractable nausea and vomiting. While the act of vomiting can strain abdominal muscles, rhythmic or sharp cramping is a localized uterine or bowel symptom that warrants a separate differential diagnosis to ensure the pregnancy remains viable and the uterus is stable.

Choice C rationale

Severe, protracted vomiting is the defining characteristic of hyperemesis gravidarum, likely linked to rapidly rising levels of human chorionic gonadotropin and estrogen. This goes beyond typical morning sickness, as the vomiting is frequent and prevents the retention of liquids or solids. This persistent gastric emptying leads to dehydration and the presence of ketones in the urine, as the body turns to lipid metabolism in the absence of glucose, which further irritates the chemical triggers for nausea.

Choice D rationale

Electrolyte imbalances occur as a direct result of losing gastric hydrochloric acid, potassium, and sodium during repeated bouts of emesis. The client may develop hypokalemia, where potassium is < 3.5 mEq/L, and metabolic alkalosis due to the loss of hydrogen ions. These imbalances interfere with normal cellular function, cardiac conduction, and nerve transmission. Maintaining homeostasis becomes difficult without intravenous fluid and electrolyte replacement to restore the normal plasma concentrations required for maternal and fetal health during gestation.

Choice E rationale

Vaginal blood spotting is not associated with hyperemesis gravidarum and is instead a warning sign of potential miscarriage, cervical irritation, or implantation issues. Hyperemesis is strictly a metabolic and gastrointestinal disorder. The presence of blood in the vaginal canal requires a pelvic exam or ultrasound to assess the cervix and placenta. Including this as an expected finding for hyperemesis would be a clinical error, as it indicates a completely different physiological process involving the reproductive tract.